Matthew Robinson
@pa4gps.bsky.social
A source of timely and evidence based Prescribing Advice for GPs and other clinicians
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of November 2025. This month there are three guidelines that impact upon primary care. The Suspected sepsis in people aged 16 or over:... https://www.prescriber.org.uk/?p=1871
November 21, 2025 at 8:03 AM
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of November 2025. This month there are three guidelines that impact upon primary care. The Suspected sepsis in people aged 16 or over:... https://www.prescriber.org.uk/?p=1871
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Budesonide suppository (Budenofalk®) has been accepted for the short-term treatment of mild to moderate acute ulcerative colitis limited to the rectum... https://www.prescriber.org.uk/?p=1870
November 12, 2025 at 8:04 AM
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Budesonide suppository (Budenofalk®) has been accepted for the short-term treatment of mild to moderate acute ulcerative colitis limited to the rectum... https://www.prescriber.org.uk/?p=1870
A Medicines Supply Notification has been distributed by NHS England and the Department of Health and Social Care advising the exenatide (Bydureon®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen has been discontinued. The notification... https://www.prescriber.org.uk/?p=1869
November 6, 2025 at 8:38 AM
A Medicines Supply Notification has been distributed by NHS England and the Department of Health and Social Care advising the exenatide (Bydureon®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen has been discontinued. The notification... https://www.prescriber.org.uk/?p=1869
During October 2025 Clinical Knowledge Summaries were published or updated in the following areas. Anticoagulation - oral Contraception - progestogen-only methods Diabetes - type 1 Earwax HIV infection and AIDS Mental health in students Osgood-Schlatter... https://www.prescriber.org.uk/?p=1868
November 4, 2025 at 8:09 AM
During October 2025 Clinical Knowledge Summaries were published or updated in the following areas. Anticoagulation - oral Contraception - progestogen-only methods Diabetes - type 1 Earwax HIV infection and AIDS Mental health in students Osgood-Schlatter... https://www.prescriber.org.uk/?p=1868
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for October 2025. This update is a call to action to improve patient safety linked to #MedSafetyWeek. This is an annual campaign taking place from 3 to... https://www.prescriber.org.uk/?p=1867
October 24, 2025 at 8:21 AM
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for October 2025. This update is a call to action to improve patient safety linked to #MedSafetyWeek. This is an annual campaign taking place from 3 to... https://www.prescriber.org.uk/?p=1867
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of October 2025. This month there is one technology appraisal and one guideline that impact upon primary care. The Mirabegron for treating... https://www.prescriber.org.uk/?p=1866
October 20, 2025 at 8:49 AM
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of October 2025. This month there is one technology appraisal and one guideline that impact upon primary care. The Mirabegron for treating... https://www.prescriber.org.uk/?p=1866
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Linzagolix (Yselty®) has been accepted for use in adult women of reproductive age for symptomatic treatment of endometriosis in women with a history of... https://www.prescriber.org.uk/?p=1865
October 14, 2025 at 6:46 AM
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Linzagolix (Yselty®) has been accepted for use in adult women of reproductive age for symptomatic treatment of endometriosis in women with a history of... https://www.prescriber.org.uk/?p=1865
The Department of Health and Social Care has recently announced a change to the prescribing restrictions for antiviral medicines for influenza. The requirement that an notification be issued by the Chief Medical Officer has been removed. Prescribing of... https://www.prescriber.org.uk/?p=1864
October 9, 2025 at 7:08 AM
The Department of Health and Social Care has recently announced a change to the prescribing restrictions for antiviral medicines for influenza. The requirement that an notification be issued by the Chief Medical Officer has been removed. Prescribing of... https://www.prescriber.org.uk/?p=1864
During September 2025 Clinical Knowledge Summaries were published or updated in the following areas. Acute childhood limp Addison's disease Baker's cyst Constipation in children Glaucoma Multiple myeloma Tiredness/fatigue in adults All of the topics have... https://www.prescriber.org.uk/?p=1863
October 6, 2025 at 6:44 AM
During September 2025 Clinical Knowledge Summaries were published or updated in the following areas. Acute childhood limp Addison's disease Baker's cyst Constipation in children Glaucoma Multiple myeloma Tiredness/fatigue in adults All of the topics have... https://www.prescriber.org.uk/?p=1863
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of September 2025. This month there are two technology appraisals, five guidelines and two health technology evaluations that impact upon... https://www.prescriber.org.uk/?p=1862
September 26, 2025 at 6:41 AM
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of September 2025. This month there are two technology appraisals, five guidelines and two health technology evaluations that impact upon... https://www.prescriber.org.uk/?p=1862
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for September 2025. This update reminds and reassures patients and clinicians that there is no evidence that taking paracetamol during pregnancy causes... https://www.prescriber.org.uk/?p=1861
September 24, 2025 at 6:36 AM
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for September 2025. This update reminds and reassures patients and clinicians that there is no evidence that taking paracetamol during pregnancy causes... https://www.prescriber.org.uk/?p=1861
The manufacturer of Levemir® (insulin detemir) has announced a decision to discontinue this product in both the pre-filled pens (FlexPen) and cartridges with supplies expected to exhausted by the end of 2026. The Specialist Pharmacy Service offers more... https://www.prescriber.org.uk/?p=1860
September 8, 2025 at 7:02 AM
The manufacturer of Levemir® (insulin detemir) has announced a decision to discontinue this product in both the pre-filled pens (FlexPen) and cartridges with supplies expected to exhausted by the end of 2026. The Specialist Pharmacy Service offers more... https://www.prescriber.org.uk/?p=1860
During August 2025 Clinical Knowledge Summaries were published or updated in the following areas. Bone and soft tissue sarcoma - recognition and referral Brain and central nervous system cancers - recognition and referral Breast cancer - recognition and... https://www.prescriber.org.uk/?p=1859
September 3, 2025 at 6:56 AM
During August 2025 Clinical Knowledge Summaries were published or updated in the following areas. Bone and soft tissue sarcoma - recognition and referral Brain and central nervous system cancers - recognition and referral Breast cancer - recognition and... https://www.prescriber.org.uk/?p=1859
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of August 2025. This month there is one health technology evaluation that impacts upon primary care. The Compression products for treating... https://www.prescriber.org.uk/?p=1858
August 28, 2025 at 7:32 AM
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of August 2025. This month there is one health technology evaluation that impacts upon primary care. The Compression products for treating... https://www.prescriber.org.uk/?p=1858
During July 2025 Clinical Knowledge Summaries were published or updated in the following areas. Coeliac disease Diabetes - type 2 Falls - assessment Immunizations - childhood Immunizations - travel Insulin therapy in type 2 diabetes Jaundice in adults... https://www.prescriber.org.uk/?p=1857
August 5, 2025 at 7:10 AM
During July 2025 Clinical Knowledge Summaries were published or updated in the following areas. Coeliac disease Diabetes - type 2 Falls - assessment Immunizations - childhood Immunizations - travel Insulin therapy in type 2 diabetes Jaundice in adults... https://www.prescriber.org.uk/?p=1857
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of July 2025. This month there are two technology appraisals and one health technology evaluation that impact upon primary care. The... https://www.prescriber.org.uk/?p=1856
July 31, 2025 at 7:12 AM
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of July 2025. This month there are two technology appraisals and one health technology evaluation that impact upon primary care. The... https://www.prescriber.org.uk/?p=1856
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for July 2025. This update warns clinicians about a small increase in the risk of Guillain-Barré syndrome following vaccination with respiratory... https://www.prescriber.org.uk/?p=1855
July 18, 2025 at 6:45 AM
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for July 2025. This update warns clinicians about a small increase in the risk of Guillain-Barré syndrome following vaccination with respiratory... https://www.prescriber.org.uk/?p=1855
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Fezolinetant (Veoza®) has been rejected for use in the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. The submitting... https://www.prescriber.org.uk/?p=1854
July 9, 2025 at 6:35 AM
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Fezolinetant (Veoza®) has been rejected for use in the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. The submitting... https://www.prescriber.org.uk/?p=1854
During June 2025 Clinical Knowledge Summaries were published or updated in the following areas. Corticosteroids - oral Hand, foot, and mouth disease Hepatitis C Immunizations - seasonal influenza Jaundice in the newborn Myalgic encephalomyelitis/chronic... https://www.prescriber.org.uk/?p=1853
July 2, 2025 at 7:07 AM
During June 2025 Clinical Knowledge Summaries were published or updated in the following areas. Corticosteroids - oral Hand, foot, and mouth disease Hepatitis C Immunizations - seasonal influenza Jaundice in the newborn Myalgic encephalomyelitis/chronic... https://www.prescriber.org.uk/?p=1853
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2025. This month there is one guideline, one technology appraisal and one health technology evaluation that impact upon primary care.... https://www.prescriber.org.uk/?p=1852
June 23, 2025 at 6:53 AM
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2025. This month there is one guideline, one technology appraisal and one health technology evaluation that impact upon primary care.... https://www.prescriber.org.uk/?p=1852
The Medicines and Healthcare products Regulatory Agency (MHRA) has published two Drug Safety Update articles for June 2025. Earlier this month updated safety and educational materials were made available to support the implementation of the regulatory... https://www.prescriber.org.uk/?p=1851
June 20, 2025 at 7:06 AM
The Medicines and Healthcare products Regulatory Agency (MHRA) has published two Drug Safety Update articles for June 2025. Earlier this month updated safety and educational materials were made available to support the implementation of the regulatory... https://www.prescriber.org.uk/?p=1851
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Bempedoic acid (Nilemdo®) has been rejected for use in adults with established or at high risk for atherosclerotic cardiovascular disease to reduce... https://www.prescriber.org.uk/?p=1850
June 10, 2025 at 7:06 AM
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Bempedoic acid (Nilemdo®) has been rejected for use in adults with established or at high risk for atherosclerotic cardiovascular disease to reduce... https://www.prescriber.org.uk/?p=1850
During May 2025 Clinical Knowledge Summaries were published or updated in the following areas. Appendicitis Corticosteroids - inhaled Cough Dupuytren's disease Menopause Neck lump Pityriasis versicolor Vitiligo All of the topics have been reviewed and... https://www.prescriber.org.uk/?p=1849
June 4, 2025 at 7:04 AM
During May 2025 Clinical Knowledge Summaries were published or updated in the following areas. Appendicitis Corticosteroids - inhaled Cough Dupuytren's disease Menopause Neck lump Pityriasis versicolor Vitiligo All of the topics have been reviewed and... https://www.prescriber.org.uk/?p=1849
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2025. This month there is one guideline and one technology appraisal that impact upon primary care. The Suspected cancer: recognition... https://www.prescriber.org.uk/?p=1848
May 28, 2025 at 7:49 AM
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2025. This month there is one guideline and one technology appraisal that impact upon primary care. The Suspected cancer: recognition... https://www.prescriber.org.uk/?p=1848
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for May 2025. This update warns clinicians of an increased risk of intrahepatic cholestasis of pregnancy (ICP) associated with thiopurines (azathioprine,... https://www.prescriber.org.uk/?p=1847
May 20, 2025 at 7:55 AM
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for May 2025. This update warns clinicians of an increased risk of intrahepatic cholestasis of pregnancy (ICP) associated with thiopurines (azathioprine,... https://www.prescriber.org.uk/?p=1847